Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Clinical trial NCT03727841 · TERMINATED
Trial details
- NCT number
- NCT03727841
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2021-04-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.